Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Trial of Oral Supplementation With Novel Mycolicibacterium (MTC 0012)

NCT07604038 is registered in ClinicalTrials.gov with Kioga Inc. as lead sponsor.

NCT NCT07604038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07604038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Trial of Oral Supplementation With Novel Mycolicibacterium (MTC 0012)
Lead sponsor
Kioga Inc.
Phase
Not applicable
Overall status
Completed
Start date
August 14, 2025
Completion date
January 15, 2026
Enrollment
107 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

general wellbeing, safety, sleep quality, stress resilience, systemic inflammation